ONC Competitors & Alternatives
Compare BeiGene, Ltd. with similar stocks in the same industry
Biotechnology
ONC
Main Stock$293.27
Tradestie Score
51
Market Cap
$36.81B
P/E Ratio
68.9
Revenue Growth
0.4%
Analyst Upside
+40.2%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$799.32
|
$46.96B | 35.8 | 63 | Compare |
|
INSM
Insmed, Inc.
|
$109.14
|
$31.13B | - | 52 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.55
|
$24.57B | - | 48 | Compare |
|
GMAB
Genmab A/S ADS
|
$26.54
|
$19.56B | 20.4 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$95.31
|
$16.93B | 13.8 | 53 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$52.85
|
$15.70B | 28.1 | 69 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.87
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$240.50
|
$12.36B | 27.2 | 60 | Compare |
|
EXEL
Exelixis Inc
|
$50.13
|
$11.09B | 16.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$29.29
|
$10.76B | - | 64 | Compare |
More ONC Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry